WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996003143) METHODS FOR TREATING BLEEDING DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/003143    International Application No.:    PCT/US1995/005439
Publication Date: 08.02.1996 International Filing Date: 27.04.1995
Chapter 2 Demand Filed:    22.12.1995    
IPC:
A61K 38/20 (2006.01)
Applicants: GENETICS INSTITUTE, INC. [US/US]; 87 Cambridge Park Drive, Cambridge, MA 02140 (US)
Inventors: KAYE, James, A.; (US)
Agent: MEINERT, M., C.; Genetics Institute, Inc., Legal Affairs, 87 CambridgePark Drive, Cambridge, MA 02140 (US)
Priority Data:
08/278,765 22.07.1994 US
Title (EN) METHODS FOR TREATING BLEEDING DISORDERS
(FR) PROCEDES DE TRAITEMENT DE TROUBLES DE SAIGNEMENT
Abstract: front page image
(EN)Provided by the present invention is a method for treating von Willebrand Disease (vWD) by administering a cytokine, such as IL-11, IL-6, LIF, OSM, or CNTF. The present invention relates generally to novel methods for treating bleeding disorders and more specifically relates to methods for treating von Willebrand Disease (vWD) hemophilia A, and various hemostatic disorders such as uremia, cirrhosis, congenital platelet defects, congenital and acquired storage pool deficiency, patients with unexplained prolongations of bleeding time, as well as prophylactic treatment before surgeries.
(FR)La présente invention se rapporte à un procédé de traitement de la maladie de von Willebrand (vWD) qui consiste à administrer une cytokine, telle que IL-11, IL-6, LIF, OSM ou CNTF. La présente invention se rapporte en général à de nouveaux procédés de traitement de la maladie de von Willebrand, l'hémophilie A, de divers troubles hémostatiques tels que l'urémie, la cirrhose, les anomalies plaquettaires congénitales, la déficience congénitale et acquise de l'accumulation sanguine, traitement s'appliquant à des patients ayant des prolongements inexpliqués de temps de saignement, ainsi qu'à des traitements prophylactiques effectués avant des interventions chirurgicales.
Designated States: AU, CA, JP.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)